Our ADP-A2M10 (MAGE-A10) T-cell therapy is directed to a member of the MAGE family of cancer testis antigens expressed in a number of solid tumor cell types. Any expression in cancer is often associated with higher grade tumors.
Please note that the two trials with ADP-A2M10 are now closed for enrollment.
Review our findings and publications.